Health and Healthcare

What Arcturus Therapeutics Brings to the Fight Against the Coronavirus

MarianVejcik / Getty Images

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stock jumped on Wednesday after the company announced that it would be joining the fight against the latest coronavirus. In terms of the specifics, Arcturus announced a partnership with Duke-NUS Medical School to develop a COVID-19 vaccine for Singapore.

The development of a COVID-19 vaccine will be based on Arcturus’s STARR technology and will take advantage of a unique platform developed at Duke-NUS allowing rapid screening of vaccines for effectiveness and safety.

Some quick background: the STARR Technology platform combines self-replicating RNA with LUNAR, a leading nanoparticle non-viral delivery system, to produce proteins inside the human body. Due to superior immune response and sustained protein expression, Arcturus’s STARR Technology is expected to produce a vaccine response at much lower doses compared to traditional mRNA vaccines.

Overall this platform could lead to the ability to treat many more people with a single GMP-manufactured production batch, thereby greatly increasing efficiency and reducing time required to produce sufficient quantities of vaccine for large populations.

Joseph Payne, president and CEO of Arcturus, commented:

We have observed STARR technology in pre-clinical models to be effective at extraordinarily low doses — greater than 30-fold more efficient than traditional mRNA.  The Arcturus manufacturing process has been applied in multiple large GMP batches of highly pure RNA in our LUNAR-OTC program.  If successful, Arcturus could develop a vaccine capable of vaccinating millions of people for a fraction of the cost of traditional mRNA vaccines.

Arcturus stock was last seen up about 19% at $17.21, in a 52-week range of $4.26 to $18.75. The consensus price target is $20.00.

The Average American Has No Idea How Much Money You Can Make Today (Sponsor)

The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.

But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.

 

Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

1 https://www.fdic.gov/national-rates-and-rate-caps

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.